Determinants of COVID-19 vaccine-induced myocarditis
Background: Following the roll-out of the Pfizer-BioNTech BNT162b2, Moderna mRNA-1273, and Janssen Ad26.COV2.S coronavirus disease 2019 (COVID-19) injections in the United States, millions of individuals have reported adverse events (AEs) using the vaccine adverse events reports system (VAERS). The...
Saved in:
Main Authors: | Jessica Rose (Author), Nicolas Hulscher (Author), Peter A. McCullough (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myocarditis in children after COVID-19 vaccine
by: Othman A Aljohani, et al.
Published: (2022) -
COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2023) -
Correction: COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2024) -
COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
by: Giuseppe Calcaterra, et al.
Published: (2021) -
Chapter Dendritic Cell Endocytosis Essential for Viruses and Vaccines
by: McCullough, Kenneth C.
Published: (2017)